Stockholm - Delayed Quote SEK

IRLAB Therapeutics AB (publ) (IRLAB-A.ST)

Compare
13.65 -0.30 (-2.15%)
At close: 5:24 PM GMT+1
All numbers in thousands
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
177,121.00
323,555.00
472,449.00
370,068.00
Total Liabilities Net Minority Interest
61,357.00
32,724.00
72,968.00
22,188.00
Total Equity Gross Minority Interest
115,764.00
290,831.00
399,481.00
347,880.00
Total Capitalization
140,275.00
290,831.00
399,481.00
347,880.00
Common Stock Equity
115,764.00
290,831.00
399,481.00
347,880.00
Capital Lease Obligations
3,055.00
3,976.00
6,600.00
2,927.00
Net Tangible Assets
68,902.00
243,969.00
356,820.00
265,869.00
Working Capital
86,856.00
236,341.00
352,038.00
262,823.00
Invested Capital
140,275.00
290,831.00
399,481.00
347,880.00
Tangible Book Value
68,902.00
243,969.00
356,820.00
265,869.00
Total Debt
27,566.00
3,976.00
6,600.00
2,927.00
Share Issued
51,868.41
51,868.41
51,748.41
48,498.41
Ordinary Shares Number
51,868.41
51,868.41
51,748.41
48,498.41
12/31/2020 - 2/28/2017

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers